Traditional Chinese medicine pair for treating radiation bowel disease and application thereof

Through the traditional Chinese medicine pairs of Qinpi and Scutellaria baicalensis, the shortcomings of radiation enteropathy were solved, and effective Chinese medicine extracts were prepared to treat radiation enteropathy, significantly alleviating symptoms and improving intestinal damage.

CN118903255AActive Publication Date: 2024-11-08FOURTH MILITARY MEDICAL UNIVERSITY
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202410900984.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-05
Publication Date
2024-11-08
Estimated Expiration
2044-07-05

AI Technical Summary

Technical Problem

The prior art lacks effective therapeutic strategies to deal with radiation enteropathy, especially intestinal injury problems common in patients after radiation therapy.

Method used

A pair of Chinese medicines, including Qinpi and Scutellaria baicalensis, is provided to prepare extracts through soaking, reflux extraction and freeze-drying, and is used for the treatment of radiation enteropathy. The drug can be used as oral or enema preparations.

Benefits of technology

The combination of Qinpi-Scutellaria baicalensis significantly reduces the symptoms of radiation intestinal disease, improves intestinal oxidative stress and inflammation, maintains intestinal barrier function, promotes cell proliferation, reduces cell apoptosis, and significantly improves intestinal damage after radiation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004930462920000051
    Figure BDA0004930462920000051
  • Figure BDA0004930462920000052
    Figure BDA0004930462920000052
  • Figure BDA0004930462920000061
    Figure BDA0004930462920000061
Patent Text Reader

Abstract

The invention discloses a traditional Chinese medicine pair for treating radiation bowel disease and application thereof, and relates to the technical field of traditional Chinese medicine preparation. The traditional Chinese medicine pair comprises the following components in parts by weight: 2-20 parts of cortex fraxini and 2-20 parts of radix scutellariae. The cortex fraxini induces astringency and stops dysentery, the radix scutellariae clears heat and dries dampness, and the compatibility of the cortex fraxini and the radix scutellariae can achieve the effects of clearing away heat and toxic materials, tonifying spleen and clearing damp and astringing intestines and stopping dysentery, and has a remarkable effect of treating the radiation bowel disease. The invention solves the problem of lack of effective drugs for treating radiation bowel diseases in the prior art.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of Chinese medicine preparation, and in particular to a Chinese medicine pair for treating radiation enteropathy and application thereof. Background Art

[0002] Radiation enteropathy is intestinal damage caused by radiation. It often occurs in patients undergoing radiotherapy, especially those with malignant tumors in the pelvic and abdominal cavities. The main clinical manifestations are abdominal pain, diarrhea, blood in the stool, mucus in the stool, and tenesmus, which seriously affect the quality of life. There is currently no effective treatment strategy for radiation enteropathy. Therefore, a therapeutic drug for radiation enteropathy is urgently needed. Summary of the invention

[0003] In order to solve the above technical problems, the purpose of the present invention is to provide a Chinese medicine pair for treating radiation enteropathy and its application, so as to solve the problem of lack of effective drugs for treating radiation enteropathy in the prior art.

[0004] The technical solution of the present invention to solve the above technical problem is as follows: a Chinese medicine pair for treating radiation enteropathy is provided, comprising the following components by weight: 2-20 parts of Fraxinus Fraxinus and 2-20 parts of Scutellaria Baicalensis.

[0005] On the basis of the above technical solution, the present invention can also be improved as follows:

[0006] Furthermore, the traditional Chinese medicine for treating radiation enteropathy comprises the following components in parts by weight: 4-20 parts of Fraxinus Fragrantis and 4-20 parts of Scutellaria Baicalensis.

[0007] Furthermore, the traditional Chinese medicine for treating radiation enteropathy comprises the following components in parts by weight: 10-15 parts of Fraxinus Fragrantis and 10-15 parts of Scutellaria Baicalensis.

[0008] The present invention also provides a method for preparing a Chinese medicinal extract for treating radiation enteropathy, which comprises the following steps in sequence:

[0009] (1) Cut the Cortex Fraxini and Radix Scutellariae Baicalensis of claim 1 or 2 into small pieces, and soak them in water respectively;

[0010] (2) reflux extraction for 1-3 times respectively, and combine the extracts;

[0011] (3) filtering, concentrating and freeze-drying to obtain freeze-dried powder, i.e., the extract of the Chinese herbal medicine for treating radiation enteropathy.

[0012] Furthermore, in step (1), the material-liquid ratio when soaking in water is 2-20 g: 80-800 mL.

[0013] Further, in step (1), water is added and soaked for 25-35 minutes.

[0014] Furthermore, in step (2), reflux extraction is performed at 100° C. for 1.5-2.5 h.

[0015] The beneficial effect of adopting the above further technical solution is: the effective substances in the Chinese medicinal materials can be fully extracted.

[0016] The present invention also provides a Chinese medicinal extract for treating radiation enteropathy prepared by the method.

[0017] The present invention also provides the use of the Chinese medicinal pair or the extract of the Chinese medicinal pair in preparing a medicine for treating radiation enteropathy.

[0018] Further, radiation enteropathy includes acute radiation intestinal injury, chronic radiation intestinal injury and ulcerative colitis.

[0019] The present invention also provides a medicine for treating radiation enteropathy, comprising the above-mentioned Chinese medicine pair or the extract of the Chinese medicine pair.

[0020] Furthermore, the dosage form of the drug is a pharmaceutically acceptable oral preparation or enema preparation.

[0021] The present invention has the following beneficial effects:

[0022] 1. The present invention is guided by modern pharmacology and provides a Chinese medicine pair and extract for treating radiation enteropathy according to the main pathogenesis and clinical symptoms of internal fire toxicity and spleen deficiency and dampness stagnation of radiation enteropathy. Qinpi has astringent and antidysentery effects, while Huangqin has heat-clearing and dampness-drying effects. The combination of Qinpi and Huangqin can play the effects of clearing away heat and detoxifying, strengthening the spleen and removing dampness, and astringing the intestines to stop diarrhea, and has a significant effect in treating radiation enteropathy.

[0023] 2. The Qinpi-Huangqin drug pair can be used to improve the shedding of intestinal villi, reduce intestinal oxidative stress and inflammatory infiltration, and maintain intestinal barrier function; it can also promote the proliferation of intestinal cells after irradiation; and reduce the apoptosis of intestinal cells after irradiation.

[0024] 3. After continuous oral administration for 7 days, the extract of Qinpi-Huangqin can significantly alleviate the symptoms of radiation enteropathy, reduce intestinal damage, and reduce the expression of inflammatory factors and cell apoptosis. Qinpi-Huangqin combination has significant therapeutic advantages in treating radiation enteropathy. DETAILED DESCRIPTION

[0025] The following is a description of the principles and features of the present invention, and the examples are only used to explain the present invention and are not intended to limit the scope of the present invention. If no specific conditions are specified in the embodiments, the conditions are carried out according to normal conditions or manufacturer recommendations. If the manufacturer is not specified for the reagents or instruments used, they are all conventional products that can be purchased commercially.

[0026] Embodiment 1:

[0027] A Chinese medicinal pair for treating radiation enteropathy comprises the following components in parts by weight: 12g of Fraxinus Fragrantis and 12g of Scutellaria Baicalensis.

[0028] A Chinese medicinal extract for treating radiation enteropathy, the preparation method of which comprises the following steps in sequence:

[0029] Cut the dried Cortex Fraxini and Radix Scutellariae into pieces, put them into 3L round-bottom flasks, add 960mL water and soak for 30min, then heat them in a heat-collecting constant temperature heating magnetic stirrer at 100℃.

[0030] The extracts were combined, filtered, and rotary evaporated to obtain a concentrated solution, which was freeze-dried to obtain a Chinese herbal medicine pair extract for treating radiation enteropathy (the crude drug extraction rate was 15-30%).

[0031] A medicine for treating radiation enteropathy, comprising the above-mentioned Chinese medicine pair for treating radiation enteropathy or an extract of the Chinese medicine pair for treating radiation enteropathy.

[0032] Embodiment 2:

[0033] A Chinese medicinal pair for treating radiation enteropathy comprises the following components in parts by weight: 4g of Fraxinus fraseri and 20g of Scutellaria baicalensis.

[0034] A Chinese medicinal extract for treating radiation enteropathy, the preparation method of which comprises the following steps in sequence:

[0035] Cut the dried Cortex Fraxini and Radix Scutellariae into pieces, put them into 3L round-bottom flasks, add 960mL water and soak for 25min, then heat them in a heat-collecting constant temperature heating magnetic stirrer at 100℃.

[0036] The extraction was refluxed for 1.5 hours under the same conditions, and each group of medicinal materials was refluxed twice. The extracts were combined, filtered, and rotary evaporated to obtain a concentrated solution, which was freeze-dried to obtain the extract of the Chinese herbal medicine for treating radiation enteropathy (the crude drug extraction rate was 15-30%).

[0037] A medicine for treating radiation enteropathy, comprising the above-mentioned Chinese medicine pair for treating radiation enteropathy or an extract of the Chinese medicine pair for treating radiation enteropathy.

[0038] Embodiment 3:

[0039] A Chinese medicinal pair for treating radiation enteropathy comprises the following components in parts by weight: 20g of Fraxinus Fraxinus and 4g of Scutellaria Baicalensis.

[0040] A Chinese medicinal extract for treating radiation enteropathy, the preparation method of which comprises the following steps in sequence:

[0041] Cut the dried Fragrant Cortex and Scutellariae Radix into pieces, put them into 3L round-bottom flasks respectively, add 960mL water and soak for 35min respectively, then reflux extract for 2.5h at 100℃ in a heat-collecting constant temperature heating magnetic stirrer, reflux each group of medicinal materials twice, combine the extracts, filter and rotary evaporate to obtain the concentrated solution, freeze-dry, and obtain the Chinese medicine pair extract for treating radiation enteropathy (the crude drug extraction rate is 15-30%).

[0042] A medicine for treating radiation enteropathy, comprising the above-mentioned Chinese medicine pair for treating radiation enteropathy or an extract of the Chinese medicine pair for treating radiation enteropathy.

[0043] Comparative Example 1:

[0044] A traditional Chinese medicine for treating radiation enteropathy comprises the following components in weight: 12g of Fraxinus fraseri.

[0045] A Chinese medicine extract for treating radiation enteropathy, the preparation method of which comprises the following steps in sequence: the same as Example 1.

[0046] A medicine for treating radiation enteropathy, comprising the above-mentioned traditional Chinese medicine for treating radiation enteropathy or a traditional Chinese medicine extract for treating radiation enteropathy.

[0047] Comparative Example 2:

[0048] A traditional Chinese medicine for treating radiation enteropathy comprises the following components in parts by weight: 12g of scutellaria baicalensis.

[0049] A Chinese medicine extract for treating radiation enteropathy, the preparation method of which comprises the following steps in sequence: the same as Example 1.

[0050] A medicine for treating radiation enteropathy, comprising the above-mentioned traditional Chinese medicine for treating radiation enteropathy or a traditional Chinese medicine extract for treating radiation enteropathy.

[0051] Test example

[0052] 1. Evaluation of intestinal pathological damage

[0053] The extracts obtained in Example 1 and Comparative Examples 1-2 were gavaged to perform an intestinal pathological damage evaluation experiment. The implementation method was as follows: the mice were divided into a normal group, a model group, a Fraxinus cortex group 2.8 g / kg, a Scutellaria baicalensis group 2.8 g / kg, and a Fraxinus cortex-Scutellaria baicalensis 2.8 g / kg group. After X-ray irradiation, the mice were gavaged for 7 consecutive days and weighed every day; samples were collected on the 8th day, and the H&E results of the mouse intestinal tissues are shown in Table 1.

[0054] Table 1 Chinese medicine and drug pairs alleviate intestinal pathological damage in RII mice

[0055]

[0056] Experimental results: As shown in Table 1, the H&E results of mouse intestinal tissue showed that the intestinal villi and intestinal crypt structures of mice in the normal group were intact, without villus breakage and inflammatory cell infiltration; after irradiation, the intestinal structure of mice was destroyed, inflammatory cells infiltrated, intestinal villi were broken, intestinal crypts were enlarged, the number of crypts decreased, and the Chiu's score increased; after drug treatment, the pathological damage of intestinal tissue of mice in the radiation injury model was alleviated, among which the Qinpi-Huangqin group had better effect than each single drug group.

[0057] 2. Evaluation of intestinal pathological damage

[0058] The extract prepared in Example 1 was administered by gavage to conduct an intestinal pathological damage evaluation experiment. The implementation method is: the mice were divided into a normal group, a model group, and a low (0.7 g / kg), medium (1.4 g / kg), and high (2.8 g / kg) dose group of Qinpi-Huangqin. After X-ray irradiation, the mice were gavaged for 7 consecutive days and weighed every day; samples were collected on the 8th day, and the H&E results of the mouse intestinal tissues are shown in Table 2.

[0059] Table 2 Chinese herbal medicines alleviate intestinal pathological damage in RII mice

[0060]

[0061]

[0062] ## P < 0.01 compared with the Control group; ** P<0.01 compared with RII group

[0063] Experimental results: After irradiation, the body weight of mice in the model group decreased significantly; administration of low, medium and high doses of Qinpi-Huangqin could inhibit the weight loss of mice, indicating that Qinpi-Huangqin can inhibit the weight loss of mice after irradiation.

[0064] As shown in Table 2, the H&E results of the intestinal tissue of mice showed that the intestinal villi and intestinal crypt structures of the normal group of mice were intact, without villus breakage and inflammatory cell infiltration; after irradiation, the intestinal structure of the mice was destroyed, inflammatory cells infiltrated, intestinal villi were broken, intestinal crypts were enlarged, the number of crypts decreased, and Chiu's score increased; after drug treatment, the breakage of villi and the enlargement of crypts could be reduced. This shows that Qinpi-Huangqin can reduce the pathological damage of intestinal tissue in radiation-damaged mice.

[0065] 3. Detection of MDA and SOD content in intestinal tissue

[0066] On the basis of the above, intestinal tissues of mice in each group were taken and the levels of total superoxide dismutase (SOD, Nanjing Jiancheng Bioengineering Research Institute Co., Ltd.) and malondialdehyde (MDA, Nanjing Jiancheng Bioengineering Research Institute Co., Ltd.) were detected according to the operating instructions of the kit. The results are shown in Table 3.

[0067] Table 3 Chinese herbal medicine pairs enhance the antioxidant capacity of intestinal tissue in RII mice

[0068]

[0069] ## P < 0.01 compared with the Control group; ** P<0.01 compared with RII group

[0070] It can be seen from Table 3 that radiation can cause the production of a large amount of reactive oxygen in the intestine, which significantly reduces the antioxidant capacity of the intestinal tissue. Compared with the normal group, the irradiation group 10Gy irradiation significantly reduced the antioxidant capacity of mice, while the administration of Fraxinus cortex-Scutellariae baicalensis can increase the antioxidant enzyme activity of mice and improve the antioxidant capacity, indicating that the Fraxinus cortex-Scutellariae baicalensis of the present invention can improve the intestinal antioxidant capacity of mice with radiation enteropathy.

[0071] IV. Detection of inflammatory factors

[0072] On the basis of the above, intestinal tissues of mice in each group were taken and the levels of inflammatory factors (IL-6, IL-10, IL-1β, TNF-α) were detected according to the operating instructions of the ELISA kit. The results are shown in Table 4.

[0073] Table 4 Chinese herbal medicines reduce the levels of inflammatory factors in the intestinal tissue of RII mice

[0074]

[0075] ## P < 0.01 compared with the Control group; ** P < 0.01 compared with the RII group; * P<0.05 compared with RII group

[0076] It can be seen from Table 4 that after irradiation, the intestinal inflammatory reaction of mice is its important pathological process. Compared with the normal group, radiation can cause a significant increase in the proinflammatory factors TNF-α, IL-1β, and IL-6, and a decrease in the anti-inflammatory factor IL-10. After administration, the expression of proinflammatory factors can be reduced and the expression of anti-inflammatory factors can be increased, indicating that the Qinpi-Huangqin of the present invention can reduce the level of intestinal inflammatory factors in mice with radiation enteropathy.

[0077] 5. Detection of intestinal proliferation in mice

[0078] On the basis of the above, the intestinal tissues of mice in each group were fixed, embedded and sliced, and Ki67 fluorescence staining was performed to detect the proliferation of the mouse intestine. Ki67 is a cell proliferation marker. The results are shown in Table 5.

[0079] Table 5 Chinese herbal medicine pairs promote cell proliferation in the intestinal tissue of RII mice

[0080]

[0081] It can be seen from Table 5 that: compared with the normal group, the number of Ki67-positive cells in the intestinal cells of mice in the radiation model group was significantly decreased, indicating that radiation significantly inhibited cell proliferation; while the number of Ki67-positive cells in the three dose groups of Fraxinus fraseri-Scutellaria baicalensis increased, indicating that Fraxinus fraseri-Scutellaria baicalensis of the present invention can promote the proliferation of intestinal tissue cells of mice after radiation.

[0082] 6. Detection of intestinal cell apoptosis

[0083] On the basis of the above, the intestinal tissues of mice in each group were fixed, embedded and sliced, and TUNEL kit was used to detect the apoptosis of intestinal cells in mice. X-rays can cause apoptosis of cells in intestinal tissues. The results are shown in Table 6.

[0084] Table 6 Chinese herbal medicine pairs inhibit apoptosis in intestinal tissue of RII mice

[0085]

[0086] ## P < 0.01 compared with the Control group; ** P < 0.01 compared with the RII group;

[0087] It can be seen from Table 6 that compared with the normal group, the apoptosis of intestinal cells in mice after irradiation was significantly increased. After administration of Fraxinus cortex-Scutellaria baicalensis, the apoptosis of intestinal cells in mice induced by X-rays can be inhibited in a dose-dependent manner, indicating that Fraxinus cortex-Scutellaria baicalensis of the present invention can inhibit the apoptosis of intestinal tissue cells in mice with radiation-induced intestinal damage.

[0088] In summary, the Chinese medicinal drug pair "Fraxinus chinensis-Scutellaria baicalensis" of the present invention is used in combination to prepare an oral preparation or oral medicine for clinical use, which can play a role in treating radiation enteropathy.

[0089] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. A Chinese medicine pair for treating radiation enteropathy, characterized in that: The invention comprises the following components in parts by weight: 2-20 parts of qinpi and 2-20 parts of scutellaria.

2. The Chinese herbal medicine pair for treating radiation enteropathy according to claim 1, characterized in that: The invention comprises the following components in parts by weight: 10-15 parts of qinpi and 10-15 parts of scutellaria.

3. A method for preparing a Chinese herbal medicine extract for treating radiation enteropathy, characterized in that: The following steps are included in sequence: (1) Cut the Cortex Fraxini and Radix Scutellariae Baicalensis of claim 1 or 2 into small pieces, and soak them in water respectively; (2) reflux extraction for 1-3 times respectively, and combine the extracts; (3) filtering, concentrating and freeze-drying to obtain freeze-dried powder, i.e., the extract of the Chinese herbal medicine for treating radiation enteropathy.

4. The method for preparing the extract of the Chinese herbal medicine pair for treating radiation enteropathy according to claim 3, characterized in that: In step (1), the material-liquid ratio when soaking in water is 2-20 g: 80-800 mL.

5. The method for preparing the extract of the Chinese herbal medicine pair for treating radiation enteropathy according to claim 3, characterized in that: In step (2), reflux extraction is performed at 100° C. for 1.5-2.5 h.

6. A Chinese herbal medicine pair extract for treating radiation enteropathy obtained by the preparation method of the Chinese herbal medicine pair extract for treating radiation enteropathy according to any one of claims 3 to 5.

7. Use of the Chinese herbal medicine pair for treating radiation enteropathy according to claim 1 or the extract of the Chinese herbal medicine pair for treating radiation enteropathy according to claim 6 in the preparation of a drug for treating radiation enteropathy.

8. The use according to claim 7, characterized in that: Radiation enteropathy includes acute radiation-induced intestinal injury, chronic radiation-induced intestinal injury, and ulcerative colitis.

9. A drug for treating radiation enteropathy, characterized in that: It comprises the Chinese herbal medicine pair for treating radiation enteropathy as described in claim 1 or the extract of the Chinese herbal medicine pair for treating radiation enteropathy as described in claim 6.

10. The drug for treating radiation enteropathy according to claim 9, characterized in that: The dosage form of the drug is an oral preparation or enema preparation permitted in pharmaceutical science.

Citation Information

Patent Citations

  • Use of ash bark in preparing radiation protection health products

    CN101361770A

  • Application of medicine composition in preparation of medicine for treating inflammatory bowel disease

    CN114306453A